Mahdi Pirsalehi, Deputy Minister of the Iranian Food and Drug Administration (IFDA), stated that Iran is facing significant difficulties in importing a range of psychotropic and neurological medications due to international sanctions and transportation restrictions. He noted that although Iran has managed to import some of the required drugs or raw materials from India, the establishment of secure and sustainable shipping routes remains constrained, and shortages of certain psychotropic medications have become apparent nationwide.